We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this ...

The board of Kenvue Inc. ( NYSE:KVUE ) has announced that it will pay a dividend of $0.205 per share on the 28th ...

Kenvue Inc. closed 4.37% below its 52-week high of $24.46, which the company achieved on November 26th.

The maker of Tylenol, a spinoff of J&J, has underperformed. But Kenvue could bounce back thanks to help from activist ...

Kenvue announced a five-year collaboration with Microsoft to transform digital operations through Artificial Intelligence (AI ...

That payout boost pushes the company's forward dividend yield up to 3.4%, more than double the S&P 500 's dividend yield of 1 ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

Kenvue Inc., has announced a five-year collaboration with Microsoft which aims to transform digital operations through ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Citi raised the firm’s price target on Kenvue (KVUE) to $22 from $21 and keeps a Neutral rating on the shares as part of a Q1 earnings preview ...

In the latest quarter, 11 analysts provided ratings for Kenvue (NYSE:KVUE), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...